Advanced search
Publication Cover
Artificial Cells, Nanomedicine, and Biotechnology
An International Journal
Volume 47, 2019 - Issue 1
Submit an article Journal homepage
1,739
Views
8
CrossRef citations to date
0
Altmetric
Retracted Article

RETRACTED ARTICLE: Ras-ERK1/2 signalling promotes the development of osteosarcoma through regulation of H4K12ac through HAT1

Jingzhe Zhanga Department of Orthopedics, China-Japan Union Hospital of Jilin University, Changchun, China
,
Meihan Liub Department of Ultrasonography, China-Japan Union Hospital of Jilin University, Changchun, China
,
Wanguo Liua Department of Orthopedics, China-Japan Union Hospital of Jilin University, Changchun, China
&
Wenjun Wanga Department of Orthopedics, China-Japan Union Hospital of Jilin University, Changchun, ChinaCorrespondence[email protected]
Pages 1207-1215 | Received 25 Jan 2019, Accepted 20 Feb 2019, Published online: 03 Apr 2019

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Gu Man, Ao Duan, Wanshun Liu, Jiangqi Cheng, Yu Liu, Jiahang Song, Haisen Zhou & Kai Shen. (2021) Circular RNA-Related CeRNA Network and Prognostic Signature for Patients with Osteosarcoma. Cancer Management and Research 13, pages 7527-7541.
Read now
Yu Song, Xia Tian, Xuehong Wang & Hui Feng. (2019) Vascular protection of salicin on IL-1β-induced endothelial inflammatory response and damages in retinal endothelial cells. Artificial Cells, Nanomedicine, and Biotechnology 47:1, pages 1995-2002.
Read now

Articles from other publishers (6)

Gentao Fan, Yan Zhu, Hao Zhu, Lingfeng Yu, Zhen Wang, Chenjun Zhai, Guangxin Zhou, Jianning Zhao & Yicun Wang. (2023) Identification of RALA as a Therapeutic Target and Prognostic Predictor of Osteosarcoma. BioMed Research International 2023, pages 1-22.
Crossref
Leyla soleymani, Ali Zarrabi, Farid Hashemi, Fardin Hashemi, Amirhossein Zabolian, Seyed Mohammad Banihashemi, Shirin Sabouhi Moghadam, Kiavash Hushmandi, Saeed Samarghandian, Milad Ashrafizadeh & Haroon Khan. (2021) Role of ZEB Family Members in Proliferation, Metastasis, and Chemoresistance of Prostate Cancer Cells: Revealing Signaling Networks. Current Cancer Drug Targets 21:9, pages 749-767.
Crossref
Zhe Hong, Zhendong Xiang, Pan Zhang, Qiang Wu, Chengdang Xu, Xinan Wang, Guowei Shi, Zongyuan Hong & Denglong Wu. (2021) Histone acetyltransferase 1 upregulates androgen receptor expression to modulate CRPC cell resistance to enzalutamide. Clinical and Translational Medicine 11:7.
Crossref
Chiao-Yun Lin, Angel Chao, Ren-Chin Wu, Li-Yu Lee, Shir-Hwa Ueng, Chia-Lung Tsai, Yun-Shien Lee, Meng-Ting Peng, Lan-Yan Yang, Huei-Jean Huang, Hsin-Shih Wang & Chyong-Huey Lai. (2020) Synergistic effects of pazopanib and hyperthermia against uterine leiomyosarcoma growth mediated by downregulation of histone acetyltransferase 1. Journal of Molecular Medicine 98:8, pages 1175-1188.
Crossref
Suresh Bugide, Keshab Raj Parajuli, Suresh Chava, Rudradip Pattanayak, Deborah L. Della Manna, Deepmala Shrestha, Eddy S. Yang, Guoping Cai, Douglas B. Johnson & Romi Gupta. (2020) Loss of HAT1 expression confers BRAFV600E inhibitor resistance to melanoma cells by activating MAPK signaling via IGF1R. Oncogenesis 9:5.
Crossref
Yuan Cheng, Cai He, Manni Wang, Xuelei Ma, Fei Mo, Shengyong Yang, Junhong Han & Xiawei Wei. (2019) Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials. Signal Transduction and Targeted Therapy 4:1.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.